ACTA’s Board of Directors is responsible for the corporate governance and financial management of the organisation. Australian Clinical Trials Alliance Limited (ACN 168 693 972) is a not-for-profit public company limited by guarantee. ACTA’s Constitution can be viewed here.
ACTA Board Members
-
Prof Christopher Reid B.A, Dip Ed, M Sc, PhD
ACTA Board Chair
Research Professor at the School of Public Health and Preventive Medicine, Monash University and the School of Population Health at Curtin University
-
Anita van der Meer M.Sc. MAICD
ACTA Board Director
Director Business Development, Health & Biosecurity – CSIRO
-
Ms Anne McKenzie, AM
ACTA Board Director
Manager, Community Engagement, Telethon Kids Institute
-
Prof David John Beard GDPhys, MCSP, MA, MSc, DPhil, FBOA (hon), FRCS (hon)
ACTA Board Director
Professor and Surgical & Complex Intervention Trials Program Lead at the NHMRC Clinical Trials Centre, Faculty of Medicine and Health, at the University of Sydney
-
Ian A R Wilson FCPA, AGIA, ACIS, MAICD
ACTA Board Director
Grant Finance Office, The Florey Institute of Neuroscience & Mental Health
-
Prof Kate Lee BSc Mathematics, MSC Medical Statistics, PhD Medical Statistics
ACTA Board Director
-
Mr Kieran Schneemann
ACTA Board Director
Director of Government Affairs, AstraZeneca. Associate Director for Canteen.
-
Prof Nadine Foster DPhil BSc(Hons) FCSP
ACTA Board Director
Academic Director – University of Queensland’s Clinical Trials Centre (UQCTC)
-
Dr Sherman Leung, PhD GDPhys, MCSP, MA, MSc, DPhil, FBOA (hon), FRCS (hon)
ACTA Board Director
Head of Research Operations at Wesley Research Institute
-
Prof Sophia Zoungas MBBS(Hons) FRACP PhD FAHMS
ACTA Board Director
Head of the School of Public Health and Preventive Medicine (SPHPM) at Monash University
-
Prof Trisha Peel – MBBS(Hons), GradCertClinRes, FRACP, PhD
ACTA Board Director
